Skip to Content

Innovation Pharmaceuticals Inc IPIX

Morningstar Rating
$0.00 0.00 (0.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

IPIX is trading at a 858% premium.
Price
$0.00
Fair Value
$1.42
Uncertainty
Extreme
1-Star Price
$2.96
5-Star Price
$9.84
Economic Moat
Ywlm
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if IPIX is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.02
Bid/Ask
$0.00 / $0.02
Market Cap
$622,017.23
Volume/Avg
3,275 / 158,526

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Innovation Pharmaceuticals Inc is a clinical-stage pharmaceutical company in the United States. It is engaged in developing therapies with oncology, dermatology, and antimicrobial applications. Its clinical trials focus on evaluating its drug candidates, including Kevetrin for the treatment of cancers; Brilacidin, a potential therapeutic for the treatment of the novel coronavirus. The company focuses on developing small molecule therapies to treat diseases in the areas of cancer, antibiotics, and inflammatory disease.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Total Number of Employees
4

Valuation

Metric
IPIX
Price/Earnings (Normalized)
Price/Book Value
0.54
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
IPIX
Quick Ratio
0.17
Current Ratio
0.19
Interest Coverage
−45.79
Quick Ratio
IPIX

Profitability

Metric
IPIX
Return on Assets (Normalized)
−32.18%
Return on Equity (Normalized)
−104.20%
Return on Invested Capital (Normalized)
−89.70%
Return on Assets
IPIX
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Novo Nordisk A/S ADR
NVO
KrgztbbxyBhkh$632.3 Bil
Vertex Pharmaceuticals Inc
VRTX
ShvtsxmcKjkngk$126.7 Bil
Regeneron Pharmaceuticals Inc
REGN
HrqjprjpPwkrdj$119.2 Bil
Moderna Inc
MRNA
YbdwmqwjCvynb$46.6 Bil
Alnylam Pharmaceuticals Inc
ALNY
SxshblczwHrlzfd$32.4 Bil
argenx SE ADR
ARGX
LbqjwvxryRllvy$27.6 Bil
BioNTech SE ADR
BNTX
TmdnkvtFhtm$20.3 Bil
Biomarin Pharmaceutical Inc
BMRN
RkgmwqzdZyqhn$16.1 Bil
United Therapeutics Corp
UTHR
KbbwrcjjpZnqnx$14.5 Bil
Incyte Corp
INCY
KsbwmmjmZcdwpyc$12.7 Bil

Sponsor Center